en
Scientific article
Review
French

Déclin cognitif vasculaire et angiopathie amyloïde cérébrale : petits vaisseaux, gros problèmes

Published inRevue médicale suisse, vol. 19, no. 824, p. 807-809
Publication date2023
Abstract

Cerebral amyloid angiopathy (CAA) is a common and well-defined small vessel disease characterized by the deposition of amyloid β in the vascular wall. CAA causes devastating outcomes related to intracerebral hemorrhage and cognitive decline in older adults. The shared pathogenic pathway between CAA and Alzheimer's disease, co-occuring frequently in the same subject, has important implications for cognitive outcomes and novel anti-amyloid-β immunotherapies. In this review, we present the epidemiology, pathophysiology, current diagnostic criteria of CAA, and future developments in the field.

engfre
Citation (ISO format)
SVEIKATA, Lukas et al. Déclin cognitif vasculaire et angiopathie amyloïde cérébrale : petits vaisseaux, gros problèmes. In: Revue médicale suisse, 2023, vol. 19, n° 824, p. 807–809. doi: 10.53738/revmed.2023.19.824.807
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 07/01/2025
Identifiers
ISSN of the journal1660-9379
10views
0downloads

Technical informations

Creation01/16/2024 3:53:14 PM
First validation04/10/2024 7:42:58 AM
Update time04/10/2024 7:42:58 AM
Status update04/10/2024 7:42:58 AM
Last indexation05/06/2024 6:21:46 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack